Tuesday, October 3, 2023
Tuesday, October 3, 2023

Contact: 561.316.3330

COSEL Launches New Compact 2”x3” Power Supply Series for Demanding Medical Applications

COSEL Co, Ltd today announced the expansion of its medical power offering with the addition of the new UMA series, the first two models being the 30W UMA30F and the 60W UMA60F. Both models feature a universal input range of 85 to 264VAC and comply with international safety standards. Designed for demanding medical applications, the UMA series is suitable for Body Floating (BF) applications and complies with 2MOPP (IN/OUT) and 1MOPP (OUT/FG) safety requirement. Based on a robust platform, the units’ design has been optimized to offer a very good price/performance ratio for medical applications requiring a high quality power solution. The UMA series is available in up to five output voltages of 5, 12, 15, 24, and 48VDC.

Medical applications are requiring robust and highly reliable power supplies that are able to operate around the world and comply with safety regulations. Based on many years of expertise, COSEL power designers developed an optimized flyback topology platform to offer an excellent price/performance ratio without compromising on quality and reliability. The UMA series can be operated within a universal Input range of 85 to 264VAC, and has a typical efficiency up to 91% at high line.

Currently four single output voltages are available as standard for the UMA30F: 5V/3A, 12V/2.5A, 24V/1.3A and 48V/0.65A, and five for the UMA60F: 5V/6A, 12V/4.5A, 15V/3.5A, 24V/2.5A and 48V/1.25A. Output is factory adjusted to a fixed value, but in applications where output voltage adjustment is required an option ‘Y’ with potentiometer is available.

The UMA series includes inrush current limiting circuitry, overcurrent, and overvoltage protection. Exhibiting versatility and robustness, the power supplies can be operated in an environmental temperature range of -20 to +70 degrees centigrade. Depending on the final equipment assembly style and cooling conditions, a derating may apply.

With its medical focus, the UMA series’ input to output isolation complies with 2MOPP, its input to Frame Ground (FG) complies with 1MOPP, and output to FG with 1MOPP. The units are approved in accordance with ANSI/AAMI ES60601-1 and EN60601-1 3rd Edition. In the case of Body Floating applications where patient leakage current must be less than 100 µA, with its 75 µA figure the UMA series is well below that limit and so eminently suitable for such applications.

The UMA series meets the following agency approvals: ANSI/AAMI ES60601-1, EN60601-1 3rd, C-UL (equivalent to CAN/CSA-C22.2 No.60601-1), UL62368-1, EN62368-1, C-UL (equivalent to CAN/CSA-C22.2 No.62368-1) and complies with EN60335-1.

To accommodate application specific requirements, three options are available including adjustable output voltage (Y), terminal block (T), and for applications requiring additional safety the UMA30F and UMA60F are available with reinforced isolation in conformance with the IEC class II (E).

The UMA30F measures 50.8 x 21.7 x 76.2mm [2.0 x 0.85 x 3.0 inches] (W x H x D) and weighs 80g max. The UMA60F is just 2.5mm taller (24.2mm) and weighs 120g max.

The UMA series has an excellent five-year warranty and conforms to the European RoHS and Low Voltage Directives.

The combination of small size, excellent cost/performance ratio, and high quality makes the UMA series an ideal power solution for demanding applications not only in the medical market but also for test and measurement, and industrial applications including household and similar electrical appliances.

SourceCOSEL
Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Centinel Spine’s prodisc ® Continues to Change Lives After Over 30 Years and 250,000 Total Disc Replacement Implantations

The prodisc lumbar and cervical technologies will be highlighted by Centinel Spine at the upcoming 2023 annual EUROSPINE meeting and congress in Frankfurt, Germany (October 4-6, 2023). The prodisc technology portfolio now includes four cervical and two lumbar devices—5 approved by the FDA—and has been validated with a reported reoperation rate of less than 1%.

Amber Implants Announces Start of Clinical Trial with VCFix® Spinal System

This first-in-human clinical trial will assess the safety and effectiveness of the VCFix® Spinal System implant for patients suffering from vertebral compression fractures. The implant is provided with a user-friendly, single-use sterile surgical kit, ensuring perfect traceability and reducing the risk of infection. 

RaySearch Deepens Collaboration with P-Cure

The expanded collaboration will enable users of the P-Cure proton therapy system to use RayStation and RayCare in a seamlessly integrated environment. The P-Cure system is a gantry-less seated proton system, designed to fit within linac vaults, that has recently been cleared by the FDA. It is used clinically by the Hadassah Medical Center in Jerusalem – the only proton facility in the Middle East – to treat CNS, head and neck, thoracic and pancreatic malignancies.

Edinburgh-based Med-tech Firm in MBO to Expand Into New Markets and Technologies

The acquisition will enable Novarum to build on its strong lateral flow test customer base and extend into adjacent markets. 

Biomic Sciences Issues Voluntary Nationwide Recall of ION* Sinus Support, ION* Biome Sinus, and Restore Sinus Spray Products Due to Microbial Contamination

Risk Statement: In the population most at risk, patients or individuals who recently underwent nasal or sinus surgery, there is a reasonable probability that the use of the affected product could potentially result in severe or life-threatening adverse events such as bacteremia or fungemia, invasive bacterial or fungal rhinosinusitis, or disseminated fungal infection. To date, Biomic Sciences has not received any reports of adverse events related to this product.

By using this website you agree to accept Medical Device News Magazine Privacy Policy